Achiko Logo cropped.jpg
Achiko’s Rapid Covid-19 Diagnostic Test AptameX™ Receives Product and Registration Approval from Indonesia’s Ministry of Health
August 25, 2021 07:30 ET | Achiko AG
AptameX™, Achiko’s breakthrough DNA aptamer-based diagnostic test for Covid-19, received product and registration emergency use approval from the Ministry of Health in Indonesia, alongside its sister...
Achiko Logo cropped.jpg
Achiko Engages EpiMetrics to Expand Covid-19 Testing Operations with Udayana University in Bali, Indonesia in the Implementation of a Mass Testing Program
July 15, 2021 07:30 ET | Achiko AG
ZURICH, Switzerland, July 15, 2021 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SWX:ACHI, ISIN CH0522213468) (“Achiko”, the “Company”), a global healthtech company...
Achiko Logo cropped.jpg
Achiko Working Towards a Solution for Frequent Global Mass COVID-19 Testing
July 13, 2021 07:30 ET | Achiko AG
ZURICH, Switzerland, July 13, 2021 (GLOBE NEWSWIRE) -- Achiko AG (SWX:ACHI, ISIN CH0522213468) (“Achiko”, the “Company”), a global healthtech company currently developing technologies that seek to...
Achiko Logo cropped.jpg
Achiko Announces an Extension of its Convertible Loan Transaction with Negma Group
June 18, 2021 12:01 ET | Achiko AG
ZURICH, June 18, 2021 (GLOBE NEWSWIRE) -- Achiko AG (SWX:ACHI, ISIN CH0522213468) (“Achiko”, the “Company”) has successfully extended the subordinated convertible loan agreement of CHF 900,000 dated...
Achiko Logo cropped.jpg
Achiko Appoints New Chief Financial Officer and Announces Changes to Senior Team
May 04, 2021 07:30 ET | Achiko AG
Appoints Robert Rieder as Chief Financial OfficerChief Operating Officer Chris Young to Retire Focus on Product Development, Lowering Cost Profile and Improved Alignment of Resources ZURICH,...
Achiko Logo cropped.jpg
Achiko’s Joint Venture Partner Obtains a Distribution Certificate for AptameX, a Novel Diagnostic Test for Covid-19 in Indonesia, and Commences Product Registration
April 29, 2021 07:30 ET | Achiko AG
Achiko AG’s Joint Venture Partner PT Indonesia Farma Medis (IFM) Obtains Medical Device Distribution CertificateAchiko Subsequently Commenced Product Registration with its Partners with a View to...
Achiko Logo cropped.jpg
Achiko Establishes Joint Venture with PT Indonesia Farma Medis for Production and Distribution of its Test Platform for Covid-19 in Indonesia
February 12, 2021 07:30 ET | Achiko AG
Achiko Signs Agreement with PT Indonesia Farma Medis to Establish a New Joint Venture, including a Contract with PT Mitra Asa Pratama and a Memorandum of Understanding with PT Pharos Indonesia,...
Achiko Logo cropped.jpg
Achiko Concludes Phase 1 Study of Project Gumnuts for Covid-19 Testing
January 25, 2021 07:30 ET | Achiko AG
Completion of Phase 1 Testing Demonstrates 91% Sensitivity and 85% SpecificityFurther Optimization Studies are Currently Being Performed and are Expected to Continue to Improve Results and Match WHO...
Achiko Logo cropped.jpg
Achiko Strengthens Leadership Team with New President and New SVP Commercialization
January 11, 2021 07:30 ET | Achiko AG
Appoints New President, Biotechnology Research Scientist and Entrepreneur Dr. Morris S. Berrie Appoints New SVP Commercialization, Business Leader in Life Science Richard Lingard New Senior Leadership...
Achiko Logo cropped.jpg
Achiko Partners with Udayana University for Covid-19 Testing Research in Bali, Indonesia
December 04, 2020 07:00 ET | Achiko AG
Achiko signed a research agreement with Udayana University’s Research Department to study the practicability of a mass testing approach with Teman Sehat and Gumnuts when availableThe Study will focus...